Silvio Veronese

18.4k citations
91 papers · 5.4k indexed · 4 hit papers · h-index 31

Silvio Veronese

88 papers receiving 5.3k citations

Hit Papers

Erlotinib versus docetaxel as second-line treatment o...3762005202620122019250500750

Peers

Silvio Veronese
Comparison fields: 5 of 107
  • Oncology 3.6k
  • Pathology and Forensic Medicine 1.5k
  • Cancer Research 1.1k
  • Pulmonary and Respiratory Medicine 2.0k
  • Hepatology 433
Replace Francesca Molinari with:
Francesca Molinari Switzerland
Milo Frattini Italy
Allen Lee Cohn United States
Rona Yaeger United States
Johannes Nippgen Germany
Shigeki Sekine Japan
Angela Zubel Germany
Samuel J. Klempner United States
Youngchul Song United States
Daniel V.T. Catenacci United States
Silvio Veronese relative to Francesca Molinari Switzerland Francesca Molinari's profile →
Citations per field
00.5×1.5×
Francesca Molinari · 1×
Citations per year

Countries citing papers authored by Silvio Veronese

Since Specialization
Citations

This map shows the geographic impact of Silvio Veronese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvio Veronese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvio Veronese more than expected).

Fields of papers citing papers by Silvio Veronese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvio Veronese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvio Veronese. The network helps show where Silvio Veronese may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Silvio Veronese, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Silvio Veronese Line = papers co-authored together Silvio Veronese links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20241
3 20235
4 20222
5 202112
6 202112
7 201814
8 20157
9 20136
10 201310
11 20125
12 201130
13
PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodiesbreakdown →
2009601
14 2007264
15 2006111
16
Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors.
200142
17 199815
18 199777
19 199692
20 199512

About Silvio Veronese

Silvio Veronese is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine, having authored 91 papers that have together received 5.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (22 papers), Lung Cancer Treatments and Mutations (18 papers), Chronic Lymphocytic Leukemia Research (13 papers), Cancer Genomics and Diagnostics (11 papers), Lymphoma Diagnosis and Treatment (11 papers), Cancer-related Molecular Pathways (9 papers), Neuroblastoma Research and Treatments (9 papers) and Genetic factors in colorectal cancer (9 papers). The work is most often cited by research in Oncology (3.6k citations), Pathology and Forensic Medicine (1.5k citations) and Cancer Research (1.1k citations). Silvio Veronese has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Salvatore Siena, Andrea Sartore‐Bianchi, Alberto Bardelli, Federica Di Nicolantonio, Mauro Moroni, Silvia Benvenuti, Marcello Gambacorta, Giovanna Marrapese, Michele Nichelatti and Carlo Zanon. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026